SELLAS Life Sciences Group Inc (SLS)
1.47
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.44
-0.03
(-2.04%)
After-Hours: 06:47
SELLAS Life Sciences Group Free Cash Flow: -30.04M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -30.04M |
December 31, 2023 | -36.91M |
September 30, 2023 | -37.24M |
June 30, 2023 | -33.09M |
March 31, 2023 | -33.29M |
December 31, 2022 | -28.31M |
September 30, 2022 | -28.13M |
June 30, 2022 | -28.26M |
March 31, 2022 | -22.90M |
December 31, 2021 | -26.02M |
September 30, 2021 | -17.62M |
June 30, 2021 | -15.37M |
March 31, 2021 | -13.86M |
December 31, 2020 | -10.42M |
September 30, 2020 | -18.02M |
June 30, 2020 | -18.21M |
March 31, 2020 | -19.48M |
December 31, 2019 | -17.64M |
September 30, 2019 | -18.02M |
June 30, 2019 | -28.37M |
March 31, 2019 | -30.01M |
December 31, 2018 | -30.42M |
September 30, 2018 | -10.62M |
June 30, 2018 | -15.84M |
March 31, 2018 | -12.59M |
Date | Value |
---|---|
December 31, 2017 | -10.99M |
September 30, 2017 | -1.167M |
June 30, 2017 | 6.011M |
March 31, 2017 | -2.431M |
December 31, 2016 | -11.85M |
September 30, 2016 | -52.28M |
June 30, 2016 | -49.58M |
March 31, 2016 | -49.96M |
December 31, 2015 | -48.31M |
September 30, 2015 | -43.80M |
June 30, 2015 | -45.43M |
March 31, 2015 | -46.84M |
December 31, 2014 | -45.34M |
September 30, 2014 | -32.68M |
June 30, 2014 | -29.63M |
March 31, 2014 | -23.91M |
December 31, 2013 | -29.25M |
September 30, 2013 | -36.24M |
June 30, 2013 | -32.33M |
March 31, 2013 | -31.50M |
December 31, 2012 | -20.97M |
September 30, 2012 | -19.96M |
June 30, 2012 | -19.21M |
March 31, 2012 | -16.54M |
December 31, 2011 | -14.72M |
Free Cash Flow Range, Past 5 Years
-37.24M
Minimum
Sep 2023
-10.42M
Maximum
Dec 2020
-24.06M
Average
-24.46M
Median
Free Cash Flow Benchmarks
Geron Corp | -184.70M |
Immuneering Corp | -50.39M |
Protagonist Therapeutics Inc | -64.16M |
Akebia Therapeutics Inc | -25.28M |
Moderna Inc | -3.672B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -10.76M |
Cash from Financing (Quarterly) | 26.65M |
Free Cash Flow Per Share (Quarterly) | -0.2401 |
Free Cash Flow Yield | -61.78% |